230 related articles for article (PubMed ID: 23978600)
1. Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.
Kyosseva SV; Chen L; Seal S; McGinnis JF
Exp Eye Res; 2013 Nov; 116():63-74. PubMed ID: 23978600
[TBL] [Abstract][Full Text] [Related]
2. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse.
Zhou X; Wong LL; Karakoti AS; Seal S; McGinnis JF
PLoS One; 2011 Feb; 6(2):e16733. PubMed ID: 21364932
[TBL] [Abstract][Full Text] [Related]
3. Sustained inhibition of neovascularization in vldlr-/- mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38/JNK-NF-κB pathway.
Cai X; Seal S; McGinnis JF
Biomaterials; 2014 Jan; 35(1):249-58. PubMed ID: 24140045
[TBL] [Abstract][Full Text] [Related]
4. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
[TBL] [Abstract][Full Text] [Related]
5. PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis.
Ye S; Chen Q; Jiang N; Liang X; Li J; Zong R; Huang C; Qiu Y; Ma JX; Liu Z
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):15. PubMed ID: 32298438
[TBL] [Abstract][Full Text] [Related]
6. Catalytic nanoceria are preferentially retained in the rat retina and are not cytotoxic after intravitreal injection.
Wong LL; Hirst SM; Pye QN; Reilly CM; Seal S; McGinnis JF
PLoS One; 2013; 8(3):e58431. PubMed ID: 23536794
[TBL] [Abstract][Full Text] [Related]
7. Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation.
Li C; Huang Z; Kingsley R; Zhou X; Li F; Parke DW; Cao W
Arch Ophthalmol; 2007 Jun; 125(6):795-803. PubMed ID: 17562991
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.
Hua J; Guerin KI; Chen J; Michán S; Stahl A; Krah NM; Seaward MR; Dennison RJ; Juan AM; Hatton CJ; Sapieha P; Sinclair DA; Smith LE
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2809-16. PubMed ID: 21282584
[TBL] [Abstract][Full Text] [Related]
9. Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria.
Cai X; Sezate SA; Seal S; McGinnis JF
Biomaterials; 2012 Dec; 33(34):8771-81. PubMed ID: 22959465
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
Jiang A; Gao H; Kelley MR; Qiao X
Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
[TBL] [Abstract][Full Text] [Related]
11. Non-toxic retention of nanoceria in murine eyes.
Cai X; Seal S; McGinnis JF
Mol Vis; 2016; 22():1176-1187. PubMed ID: 27746672
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
13. Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1.
Joyal JS; Sun Y; Gantner ML; Shao Z; Evans LP; Saba N; Fredrick T; Burnim S; Kim JS; Patel G; Juan AM; Hurst CG; Hatton CJ; Cui Z; Pierce KA; Bherer P; Aguilar E; Powner MB; Vevis K; Boisvert M; Fu Z; Levy E; Fruttiger M; Packard A; Rezende FA; Maranda B; Sapieha P; Chen J; Friedlander M; Clish CB; Smith LE
Nat Med; 2016 Apr; 22(4):439-45. PubMed ID: 26974308
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.
Dorrell MI; Aguilar E; Jacobson R; Yanes O; Gariano R; Heckenlively J; Banin E; Ramirez GA; Gasmi M; Bird A; Siuzdak G; Friedlander M
J Clin Invest; 2009 Mar; 119(3):611-23. PubMed ID: 19188685
[TBL] [Abstract][Full Text] [Related]
15. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic Applications of Cerium Oxide Nanoparticles.
Maccarone R; Tisi A; Passacantando M; Ciancaglini M
J Ocul Pharmacol Ther; 2020; 36(6):376-383. PubMed ID: 31891528
[TBL] [Abstract][Full Text] [Related]
17. Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization.
Xia CH; Lu E; Zeng J; Gong X
PLoS One; 2013; 8(9):e75186. PubMed ID: 24058663
[TBL] [Abstract][Full Text] [Related]
18. Retinal long term neuroprotection by Cerium Oxide nanoparticles after an acute damage induced by high intensity light exposure.
Tisi A; Passacantando M; Lozzi L; Riccitelli S; Bisti S; Maccarone R
Exp Eye Res; 2019 May; 182():30-38. PubMed ID: 30867118
[TBL] [Abstract][Full Text] [Related]
19. HL-217, a new topical anti-angiogenic agent, inhibits retinal vascular leakage and pathogenic subretinal neovascularization in Vldlr⁻/⁻ mice.
Kim J; Kim CS; Jo K; Cho YS; Kim HG; Lee GH; Lee YM; Sohn E; Kim JS
Biochem Biophys Res Commun; 2015 Jan; 456(1):53-8. PubMed ID: 25446077
[TBL] [Abstract][Full Text] [Related]
20. The role of Vldlr in intraretinal angiogenesis in mice.
Xia CH; Lu E; Liu H; Du X; Beutler B; Gong X
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6572-9. PubMed ID: 21757581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
